SureTrader Advertisement Advertisement Advertisement
Home > Boards > US OTC > Medical - Drugs >

Cellceutix Corporation (CTIX)

Add CTIX Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator BigKahuna, BooDog, KarinCA, noretreat, TOB, starbuxsux
Search This Board:
Last Post: 10/6/2015 9:46:08 AM - Followers: 651 - Board type: Free - Posts Today: 35

Cellceutix Corporation (CTIX)
Company Address:
100 Cumming Center, Suite 151-B
Beverly, MA 01915
Phone: 978-236-8717
Fax:  978-921-6564
CIK:  0001355250
Cellceutix is a publicly traded company under the symbol “CTIX”. Cellceutix is a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology and antibiotic applications. Cellceutix believes it has a world-class portfolio of compounds and is now engaged in advancing its compounds and seeking strategic partnerships. Cellceutix’s anti-cancer drug Kevetrin is currently in a Phase 1 clinical trial at Harvard Cancer Centers’ Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center. In the laboratory Kevetrin has shown to induce activation of p53, often referred to as the “Guardian Angel Gene” due to its crucial role in controlling cell mutations. Cellceutix is planning a Phase 2 clinical trial with its novel compound Brilacidin-OM for the prevention and treatment of Oral Mucositis. Brilacidin-OM, a defensin mimetic compound, has shown in the laboratory to reduce the occurrence of severe ulcerative oral mucositis by more than 94% compared to placebo. Cellceutix’s anti-psoriasis drug Prurisol is presently in a bioequivalence crossover clinical trial in Miami, FL. Prurisol is a small molecule that acts through immune modulation and PRINS reduction. Cellceutix’s key antibiotic, Brilacidin, is in a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infections, or ABSSSI. Brilacidin has the potential to be a single-dose therapy or a dosing regimen that is shorter than currently marketed antibiotics for multi-drug resistant bacteria (Superbugs). Cellceutix has formed research collaborations with world-renowned research institutions in the United States and Europe, including MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, and the University of Bologna.


The above link is kept updated.

Ongoing Human Trials:
Product Pipeline:

Recent News and Press Releases:

Seeking Alpha focus articles on CTIX:

A randomized, double-blind study comparing single-dose and short-course brilacidin to daptomycin in the treatment of acute bacterial skin & skin structure infections (ABSSSI)

Synthetic novel host defense protein mimetics for the treatment of Gram-negative bacterial infections

SEC Filings:

Transfer Agent:
West Coast Stock Transfer, Inc.
721 N. Vulcan Ave. Ste. 205
Encinitas, CA 92024
(619) 664-4780 p
(760) 452-4423 f

Share Structure:  See SEC filing link above for current share structure

Cellceutix IP - Patent Filings:

Publication number US8338454 B2
Publication type Grant
Application number US 12/780,132
Publication date Dec 25, 2012
Filing date May 14, 2010
Priority date May 20, 2009
Also published as CA2762427A1, CN102438612A, EP2432464A2, US20100298374, US20130245062, WO2010135170A2, WO2010135170A3, Less «6 More »
Publication number 12780132, 780132, US 8338454 B2, US 8338454B2, US-B2-8338454, US8338454 B2, US8338454B2
Inventors Krishna Menon
Original Assignee Cellceutix Corporation
Export Citation BiBTeX, EndNote, RefMan
Patent Citations (6), Non-Patent Citations (41), Referenced by (1), Classifications (42)
External Links: USPTO, USPTO Assignment, Espacenet

Investor Relations:

Following is a WEEKLY chart:


All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
CTIX News: Special Profile Coming and 4 Analyst Reports 07/21/2015 07:00:00 AM
CTIX News: Undervalued and Underexposed NYSE-MKT Stock to be Profiled by Large Media Group and four brief reports 06/15/2015 07:00:00 AM
CTIX News: Special Profile & Four Companies Where Investors are Anticipating Success 06/03/2015 07:00:00 AM
CTIX News: *Special Analyst Alert* and 4 Companies that are Worth a Look 05/13/2015 07:00:00 AM
CTIX News: Quarterly Report (10-q) 05/11/2015 02:03:16 PM
#124679  Sticky Note Just to reiterate what was previous said and bejamin 10/06/15 08:27:16 AM
#121761  Sticky Note Cellceutix Announces Filing of its Annual Report on TOB 09/14/15 09:28:06 AM
#120460  Sticky Note Cellceutix’s Prurisol: A Potential Blockbuster Psoriasis Treatment TOB 08/28/15 03:20:01 PM
#119441  Sticky Note Cellceutix's Clinical Trial of Anti-Cancer Agent Kevetrin Meeting starbuxsux 08/20/15 03:41:27 PM
#118219  Sticky Note $CTIX - My visit to Cellceutix, the biotech KarinCA 08/14/15 02:19:08 PM
#117003  Sticky Note Cellceutix released efficacy data for Kevetrin, its cancer TOB 08/09/15 03:05:24 PM
#124687   Exact opposite of common sense, actually. Common sense frrol 10/06/15 09:46:08 AM
#124686   Meanwhile...CTIX: PK $1.36 TheDane 10/06/15 09:41:55 AM
#124685   You are living up to your handle "Amateur" luxe 10/06/15 09:41:51 AM
#124684   Bobby, what is your agenda? taas 10/06/15 09:41:42 AM
#124683   Great post filled with common sense! It's AlanC 10/06/15 09:01:42 AM
#124682   good post bejamin redwing992006 10/06/15 09:01:23 AM
#124681   There are more than two trials and tests frrol 10/06/15 08:54:31 AM
#124680   And the LOANRANGER rides again. Thanks young man wild4ctix 10/06/15 08:50:34 AM
#124679   Just to reiterate what was previous said and bejamin 10/06/15 08:27:16 AM
#124675   Whatever investment plan you're using should include actually BooDog 10/06/15 07:57:33 AM
#124674   Actually time will tell if the long term Amatuer17 10/06/15 07:44:25 AM
#124671   Patience while our multi BILLION $ market cap BooDog 10/06/15 07:26:22 AM
#124670   So I see that many say Leo is BobbyKIrk 10/06/15 07:16:05 AM
#124669   "LR, I found the compensation agreement between CTIX loanranger 10/06/15 06:38:03 AM
#124668   There is incredible ignorance and a disconnect by Justfactsmam 10/06/15 06:04:18 AM
#124667   Why partner when we are funded for 2 Dynarod 10/06/15 05:55:44 AM
#124665   We are dropping due to market risk factors Dynarod 10/06/15 05:52:17 AM
#124664   Great post Barron....I agree and it really is Chemdeps 10/06/15 05:41:55 AM
#124663   Good post but SADLY that advice will fall 25 Kilos of Gold 10/06/15 05:02:49 AM
#124662   No, that is not correct. A compound that sunspotter 10/06/15 04:26:00 AM
#124661   Awesome post! Understanding what you've written is what BioCowboy 10/06/15 04:10:19 AM
#124660   Hope everyone has some dry powder because when incubus-now 10/06/15 02:23:38 AM
#124659   Just a followup to my previous post. Note Barron4664 10/06/15 02:01:02 AM
#124658   I think you are seriously confused here. Waverunner1 10/06/15 01:24:01 AM
#124657   The compounds would be available to the purchaser Rdunn88 10/06/15 01:08:30 AM
#124656   And what? My debate with LR was about Rdunn88 10/06/15 12:55:23 AM
#124655   and........ incubus-now 10/06/15 12:47:58 AM
#124654   LR, I found the compensation agreement between CTIX Rdunn88 10/06/15 12:36:07 AM
#124653   The rabbit flag just went up: we are BigKahuna 10/06/15 12:19:38 AM
#124652   $1.30 must hold. TheBunny 10/05/15 11:52:04 PM
#124650   Agree 100%. Fortunately Leo isn't reading this board. sox040713 10/05/15 11:46:54 PM
#124649   Why would any sane shareholder want bankruptcy of sox040713 10/05/15 11:40:14 PM
#124648   Here is the Rosen lawfirms own explanation for F1ash 10/05/15 11:31:30 PM
#124647   Well put... thefamilyman 10/05/15 11:30:47 PM
#124646   If Leo is as incompetent as the PolyMedix sox040713 10/05/15 11:30:23 PM
#124645   Blanket statement. ACanJadaS 10/05/15 11:29:25 PM
#124644   It's not the only hope , if he WHcraftsman 10/05/15 11:23:43 PM
#124643   Very well said. The majority don't find Leo's TimetoRetire 10/05/15 11:06:52 PM
#124639   That was a good analogy. Leo announced 'Mr President Amatuer17 10/05/15 10:38:32 PM
#124636   At this rate we will hit $1 on tombrady12nh 10/05/15 10:13:27 PM
#124635   No, that's not what it's like. Its about Cognition 10/05/15 10:12:35 PM
#124634   Thats like saying I own the most expensive TimetoRetire 10/05/15 09:56:36 PM
#124633   Touché my friend... Looping 10/05/15 09:46:47 PM
#124632   I'm the loser police and my sirens are faraifarai 10/05/15 09:40:40 PM
#124631   "KNOW WHAT YOU OWN." The science is going faraifarai 10/05/15 09:39:24 PM
#124629   a partnership will come before 2016. faraifarai 10/05/15 09:35:56 PM
#124628   I think he should partner b for phase akamaii 10/05/15 09:33:12 PM
#124625   YTD perf -63% Looping 10/05/15 09:31:18 PM
#124624   We need to get the Phase 3 trial Matagordaville 10/05/15 09:27:31 PM
#124623   He is running a company with his investor's TimetoRetire 10/05/15 09:25:09 PM